Aspen Neuroscience, Inc. is left out of our screens and market counts tonight, which cover US stocks priced at $5 or more and trading at least $1 million a day on average. Its read below still updates after every close.
Aspen Neuroscience, Inc.
Every stock that changed stage on Oct 30, 2026 →
Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases. More about the company
Pro read
ProOur read
Setup score
Momentum
Is ASPE early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
ASPE among Biotechnology
All 237 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | IOVA | Stage 2 · wk 20 | 99 | −37.6% |
| 2 | SLS | Stage 3 · wk 6 | 99 | −23.7% |
| 3 | MRNA | Stage 2 · wk 19 | 99 | +12.4% |
| 4 | SYRE | Stage 3 · wk 6 | 99 | +7.1% |
| 5 | TWST | Stage 2 · wk 41 | 99 | −31.6% |
| 6 | KOD | Stage 2 · wk 5 | 99 | +5.4% |
| 7 | ERAS | Stage 3 · wk 6 | 99 | −0.5% |
| 8 | CLYM | Stage 3 · wk 5 | 99 | −11.8% |
Against its industry
Biotechnology · 592 companies we cover
- Profit margin0.0%
Wider margin than 18%
- Debt to equity0.11x
Less debt than 43%
Aspen Neuroscience: quick answers
Which sector and industry is Aspen Neuroscience in?
Aspen Neuroscience is in the Biotechnology industry, part of the Health Care sector. 187 stocks in Health Care are in Stage 2, 37.4% of the sector. See the Stage 2 stocks in Biotechnology
About this companyHealth Care· Biotechnology
Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases. The company's develops ANPD001, an investigational single-dose, autologous dopaminergic neuronal precursor cell (DANPC) therapy for Parkinson's disease. It operates in the United States. The company also advances additional cell replacement candidates targeting both sporadic and genetic forms of Parkinson's disease, as well as other candidates for conditions of the central nervous system (CNS). Aspen Neuroscience, Inc. was formerly known as Aspen Biosciences, Inc. and changed its name to Aspen Neuroscience, Inc. in October 2018. Aspen Neuroscience, Inc. was incorporated in 2018 and is based in San Diego, California.
Visit company website →All analytics based on EOD data. Data as of 2026-11-03. Past data patterns are not indicative of future results. This page is a data analytics tool only.